<SEC-DOCUMENT>0001415889-23-002456-index.html : 20230214
<SEC-HEADER>0001415889-23-002456.hdr.sgml : 20230214
<ACCEPTANCE-DATETIME>20230214164556
ACCESSION NUMBER:		0001415889-23-002456
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230210
FILED AS OF DATE:		20230214
DATE AS OF CHANGE:		20230214

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Wang Theodore T
		CENTRAL INDEX KEY:			0001694061

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36845
		FILM NUMBER:		23630766

	MAIL ADDRESS:	
		STREET 1:		C/O PUISSANCE CAPITAL MANAGEMENT LP
		STREET 2:		950 THIRD AVENUE, 25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bellerophon Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001600132
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				473116175
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		184 LIBERTY CORNER ROAD, SUITE 302
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059
		BUSINESS PHONE:		908-574-4770

	MAIL ADDRESS:	
		STREET 1:		184 LIBERTY CORNER ROAD, SUITE 302
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bellerophon Therapeutics LLC
		DATE OF NAME CHANGE:	20140213
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-02142023_040222.xml
<TEXT>
Document 1 - file: form4-02142023_040222.html

Document 1 - RAW XML: form4-02142023_040222.xml

</DOCUMENT>
</SEC-DOCUMENT>